NCT00656890 - A Study of MDX-1100 in Subjects With Active Ulcerative Colitis | Biotech Hunter

Enrollment

110

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Ulcerative Colitis

Interventions

BIOLOGICAL

sterile saline for injection

10mg/kg/dose sterile saline injected every other week for a total of 4 doses

BIOLOGICAL

MDX-1100

10mg/kg/dose MDX-1100 injected every other week for a total of 4 doses

Trial Locations (44)

10029

Mount Sinai School of Medicine, New York

20815

Chevy Chase Clinical Research, Chevy Chase

32127

Advanced Medical Research Center, Port Orange

33613

Florida Medical Clinic-Tampa Clinic, Tampa

45415

Dayton Science Institute, Dayton

60611

Northwestern University Feinberg School of Medicine, Chicago

63110

Washington University School of Medicine, St Louis

V2S 3N5

Abbotsford

V5Z 1H2

Vancouver

M3N 2V7

Toronto

Unknown

Olomouc

Prague

Strakonice

Tábor

Ústí nad Labem

Valasske Mezifici

Budapest

Debrecen

Gyula

Kaposvár

Kecskemét

Nagykanizsa

Siófok

Vác

Zalaegerszeg

Daugavpils

Riga

Valmiera

Bucharest

Cluj-Napoca

Oradea

Tg. Mures

Timișoara

Moscow

Saratov

Yaroslavl

Chernivtsy

Dniepropetrovsk

Donetsk

Kharkiv

Kiev

Kyiv

Lviv

Simferopol